SOBRsafe Postpones Annual General Meeting Amid Unresolved Dissolution Speculation

SOBRsafe, Inc. (OTC: SOBR) has postponed its Annual General Meeting until further notice to address news that the company believes requires clarification regarding its corporate status. The Denver-based firm stated it is currently exploring and considering its options moving forward, but emphasized that no decision has been made by the Board of Directors or its stockholders to dissolve the company.

The press release, issued on October 2, 2026, serves as a response to external reports suggesting a potential wind-down of operations. Management clarified that while the company is evaluating its path, the legal entity remains active and has not entered a dissolution process. The postponement of the shareholder meeting allows the board to finalize its strategic direction without the immediate pressure of an upcoming vote.

SOBRsafe’s core technology involves advanced transdermal sensors that detect and report alcohol presence in real-time through a user's skin. The system does not require breath, blood, or urine samples. The company provided passive screening and monitoring solutions for the behavioral health, family law, and consumer markets, alongside licensing and integration services for third-party developers.

The release includes a standard safe harbor statement under Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. The company notes that forward-looking statements are based on current expectations and forecasts, which are subject to business risks and uncertainties beyond management's control. Actual results may differ materially from these projections due to inaccurate assumptions or external factors. Investors are cautioned not to place undue reliance on such statements, and the company does not undertake to update them publicly unless required by law.

David Gandini, Chief Executive Officer, is the designated point of contact for further inquiries. The company’s additional filings containing detailed risk factors are available on the SEC’s website.